Hunter E F, Smith J F, Lewis J S, McGrew B E, Schmale J D
Infect Immun. 1972 Jun;5(6):858-62. doi: 10.1128/iai.5.6.858-862.1972.
Fluorescein-labeled anti-human globulins were examined to determine the need for standardization of conjugates used in the fluorescent treponemal antibody-absorption (FTA-ABS) test. Twenty-one of 33 conjugates submitted by commercial manufacturers to the Reagents Control Activity, Venereal Disease Research Laboratory, for evaluation in the FTA-ABS test were available for study. Conjugates, after evaluation in FTA-ABS performance tests, were examined by immunoelectrophoresis, by titration against immunoglobulins G and M (IgG, IgM) with FTA-ABS techniques, and by the biuret protein and fluorescein diacetate methods for determining fluorescein to protein (F/P) ratios. The conjugates were predominately anti-IgG globulin with anti-light-chain activity. Differences were noted in the ability of some conjugates to detect IgM antibody. The F/P ratios of those conjugates that could be determined varied from 2.6 to 17.8 mug of fluorescein per mg of protein. The need to identify and standardize both the immunologic capabilities and the optimum F/P ratio for FTA-ABS test conjugates is presented.
对荧光素标记的抗人球蛋白进行了检测,以确定荧光密螺旋体抗体吸收试验(FTA-ABS)中所用结合物标准化的必要性。商业制造商提交给性病研究实验室试剂控制部门用于FTA-ABS试验评估的33种结合物中有21种可供研究。在FTA-ABS性能试验中评估后的结合物,通过免疫电泳、用FTA-ABS技术针对免疫球蛋白G和M(IgG、IgM)进行滴定以及用双缩脲蛋白和荧光素二乙酸酯法测定荧光素与蛋白质(F/P)比率进行检测。这些结合物主要是具有抗轻链活性的抗IgG球蛋白。注意到一些结合物在检测IgM抗体能力方面存在差异。能够测定的那些结合物的F/P比率在每毫克蛋白质含2.6至17.8微克荧光素之间变化。提出了识别和标准化FTA-ABS试验结合物的免疫能力和最佳F/P比率的必要性。